United States SRES 422: A resolution recognizing the seriousness of polycystic ovary syndrome (PCOS) and expressing support for the designation of September 2025 as "PCOS Awareness Month".

Bill Text

III 
119THCONGRESS 
1
STSESSION 
S.  RES.  422 
Recognizing  the  seriousness  of  polycystic  ovary  syndrome  (PCOS)  and  ex-
pressing   support   for   the   designation   of   September   2025   as   ‘‘PCOS   
Awareness Month’’. 
IN  THE  SENATE  OF  THE  UNITED  STATES  
SEPTEMBER30, 2025 
Ms.  W
ARREN(for  herself,  Mrs.  FISCHER,  Mr.  BLUMENTHAL,  Mr.  PADILLA, 
Mr.  V
ANHOLLEN,  Mr.  MARSHALL,  Mr.  LANKFORD,  and  Mr.  WARNOCK) 
submitted  the  following  resolution;  which  was  referred  to  the  Committee  
on Health, Education, Labor, and Pensions 
RESOLUTION 
Recognizing   the   seriousness   of   polycystic   ovary   syndrome   
(PCOS)  and  expressing  support  for  the  designation  of  
September 2025 as ‘‘PCOS Awareness Month’’. 
Whereas  polycystic  ovary  syndrome  (referred  to  in  this  pre-
amble  as  ‘‘PCOS’’)  is  a  common  health  problem  among  
women and girls involving a hormonal imbalance; 
Whereas  there  is  no  universal  definition  of  PCOS,  but  re-
searchers   estimate   that   10   percent   of   women   in   the   
United States are affected by the condition; 
Whereas,  according  to  a  2023  study,  the  annual  burden  of  
PCOS  in  the  United  States  is  estimated  to  be  in  excess  
of  $15,000,000,000,  and  this  estimate  does  not  include—  
VerDate Sep 11 2014     00:35 Oct 01, 2025    Jkt 059200    PO 00000    Frm 00001    Fmt 6652    Sfmt 6300    E:\BILLS\SR422.IS    SR422
kjohnson on DSK7ZCZBW3PROD with $$_JOB

2 
•SRES  422  IS  
(1)  the  cost  of  all  comorbidities  in  post-menopause  
or adolescence; or 
(2)  indirect  and  intangible  costs  related  to  the  dis-
order; 
Whereas  PCOS  can  affect  girls  at  the  onset  of  puberty  and  
throughout the remainder of their lives; 
Whereas  the  symptoms  of  PCOS  include  infertility,  irregular  
or  absent  menstrual  periods,  acne,  weight  gain,  thinning  
of  scalp  hair,  excessive  facial  and  body  hair  growth,  nu-
merous   small   ovarian   cysts,   pelvic   pain,   and   mental   
health problems; 
Whereas  women  with  PCOS  have  higher  rates  of  mental  
health  disorders,  including  depression,  anxiety,  bipolar  
disorder,  and  eating  disorders,  and  are  at  greater  risk  for  
suicide; 
Whereas  adolescents  with  PCOS  often  are  not  diagnosed,  and  
many  have  metabolic  dysfunction  and  insulin  resistance,  
which  can  lead  to  type  2  diabetes,  cardiovascular  disease,  
obstructive  sleep  apnea,  nonalcoholic  fatty  liver  disease,  
heart  disease,  and  endometrial  cancer  at  a  young  adult  
age; 
Whereas  an  estimated  70  percent  of  women  with  PCOS  are  
undiagnosed  and  many  remain  undiagnosed  until  they  ex-
perience  fertility  difficulties  or  develop  type  2  diabetes  or  
other cardiometabolic disorders; 
Whereas  PCOS  is  one  of  the  most  common  causes  of  female  
infertility; 
Whereas  PCOS  in  pregnancy  is  associated  with  increased  risk  
of  gestational  diabetes,  preeclampsia,  pregnancy-induced  
hypertension,  preterm  delivery,  cesarean  delivery,  mis-
carriage, and fetal and infant death; 
VerDate Sep 11 2014     00:35 Oct 01, 2025    Jkt 059200    PO 00000    Frm 00002    Fmt 6652    Sfmt 6300    E:\BILLS\SR422.IS    SR422
kjohnson on DSK7ZCZBW3PROD with $$_JOB

3 
•SRES  422  IS  
Whereas  women  with  PCOS  are  at  increased  risk  of  devel-
oping  high  blood  pressure,  high  cholesterol,  stroke,  and  
heart  disease  (the  leading  cause  of  death  among  women);  
Whereas  women  with  PCOS  have  a  more  than  50  percent  
chance  of  developing  type  2  diabetes  or  prediabetes  be-
fore the age of 40; 
Whereas  PCOS  may  be  associated  with  increased  risk  for  
breast  cancer  and  ovarian  cancer,  and  the  risk  of  devel-
oping   endometrial   cancer   is   4   times   higher   than   for   
women who do not have PCOS; 
Whereas  research  has  found  an  association  between  depres-
sion and PCOS; 
Whereas  research  has  indicated  PCOS  shares  a  genetic  archi-
tecture  with  metabolic  traits,  as  evidenced  by  genetic  cor-
relations  between  PCOS  and  obesity,  fasting  insulin,  type  
2 diabetes, lipid levels, and coronary artery disease; 
Whereas   PCOS   negatively   alters   metabolic   function   inde-
pendent  of,  but  exacerbated  by,  an  increased  body  mass  
index (commonly referred to as ‘‘BMI’’); 
Whereas  the  cause  of  PCOS  is  unknown,  but  researchers  
have  found  strong  links  to  a  genetic  predisposition  and  
significant  insulin  resistance,  which  affects  up  to  70  per-
cent of women with PCOS; and 
Whereas  there  is  no  known  cure  for  PCOS:  Now,  therefore,  
be it 
Resolved, That the Senate— 1
(1)  recognizes  polycystic  ovary  syndrome  (re-2
ferred  to  in  this  resolution  as  ‘‘PCOS’’)  as  a  serious  3
disorder  that  impacts  many  aspects  of  health,  in-4
VerDate Sep 11 2014     00:35 Oct 0